Table:
begin	end	state
1	8	cytoplasmic
9	27	transmembrane
28	32	non-cytoplasmic
33	54	transmembrane
55	61	cytoplasmic
62	80	transmembrane
81	107	non-cytoplasmic
108	136	transmembrane
137	143	cytoplasmic
144	162	transmembrane
163	181	non-cytoplasmic
182	208	transmembrane
209	229	cytoplasmic
230	249	transmembrane
250	268	non-cytoplasmic
269	288	transmembrane
289	299	cytoplasmic
300	323	transmembrane
324	334	non-cytoplasmic
335	358	transmembrane
359	364	cytoplasmic
365	384	transmembrane
385	389	non-cytoplasmic
390	413	transmembrane
414	424	cytoplasmic
425	449	transmembrane
450	450	non-cytoplasmic

Input:
>AO353_03245
MFGMSHESFLLLDAVITVIGLIVLITKFKLHPFIALIIAAAFLGLTSGMPIGTIIKAFQD
GFGGVLGFVGIILALGTMLGKMMAESGGADQIAQTLIRAFGKERVQWAMMFAAFLVGIPL
FFEIGFVLLIPLVFIVARRTGVSIIKIGIPLLAGLSAVHGLVPPHPGPLLAIGVFGADIG
KTILYGLIVALPTAIIAGPIYGTFIAKYIPGHPNQELVDQLAREPHSSTLPSFSITLITV
LLPVFLMLLKTFADIALPDGHFFRTWMDMIGHPISALLLALLLSLYTFGHRQGIGSKQIL
KLLDASLAPTAAIILIIGAGGGFKQMLVTSGVGDVIGHMAVSAQISPILLAWLVAAVIRV
ATGSATVATITGAGIVVPVVGMIPGVNRELLVLATGAGSLILSHVNDAGFWLVKQYFNMT
VAETFKTWTAMETILSVVALGFILLLSLVV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server